FindMyRecallSubscribe
Class I: serious health riskTerminated

Alvogen FENTANYL Transdermal System Recall

FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Dis…

Alvogen, Inc · Pine Brook, NJ

Risk level
Class I
Reported by FDA
May 15, 2019
Recall ID
D-1277-2019
Check your lot numberHow we source this data

Summary

Alvogen recalled FENTANYL Transdermal System starting Apr 19, 2019. The FDA classified it as Class I (serious health risk) and published enforcement report D-1277-2019 on May 15, 2019. Reason: Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h. Status: Terminated.

Why it was recalled

Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.

Product description

FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058; Manufactured by: 3M Drug Delivery Systems, St. Paul, MN 55107, NDC 47781-423-47.

Lot numbers, UPCs & expiration codes

Lot#: 180060, Exp 05/2020; 180073, Exp 06/2020.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1277-2019
Classification
Class I
Status
Terminated
Recall initiated
Apr 19, 2019
FDA report date
May 15, 2019
Quantity
119,608 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Alvogen, Inc

Original FDA data

Every field from FDA enforcement report D-1277-2019, exactly as published.

Show all FDA fields
City
Pine Brook
State
NJ
Status
Terminated
Country
United States
Event ID
82669
Address
10 Bloomfield Ave Bldg B Ste 2
Code information
Lot#: 180060, Exp 05/2020; 180073, Exp 06/2020.
Postal code
07058-9743
Report date
May 15, 2019
Product type
Drugs
Recall number
D-1277-2019
Classification
Class I
Recalling firm
Alvogen, Inc
Product quantity
119,608 cartons
Termination date
Aug 14, 2019
Reason for recall
Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.
Voluntary / mandated
Voluntary: Firm initiated
Product description
FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058; Manufactured by: 3M Drug Delivery Systems, St. Paul, MN 55107, NDC 47781-423-47.
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 19, 2019
Initial firm notification
Press Release
Center classification date
May 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1277-2019, published May 15, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls